Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Hull

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]Prashant Patel, J Graham Young, Vivien Mautner, et al.
Lancet (London, England)|November 27, 2015
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 studyMatthew James Armstrong, Piers Gaunt, Guruprasad P Aithal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Addition of dendritic cell vaccination to conditioning cyclophosphamide and chemoembolisation in patients with hepatocellular carcinoma: the ImmunoTACE trialYuk Ting Ma, Jianmin Zuo, Amanda Kirkham, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2017
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trialPhilip Noel Newsome, Richard Fox, Andrew L King, et al.
Hepatology Communications|April 26, 2024
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trialGideon M Hirschfield, Katherine Arndtz, Amanda Kirkham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancerDaniel H Palmer, Vivien Mautner, Darius Mirza, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984]Prashant Patel, J Graham Young, Vivien Mautner, et al.
Lancet (London, England)|November 27, 2015
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 studyMatthew James Armstrong, Piers Gaunt, Guruprasad P Aithal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
Addition of dendritic cell vaccination to conditioning cyclophosphamide and chemoembolisation in patients with hepatocellular carcinoma: the ImmunoTACE trialYuk Ting Ma, Jianmin Zuo, Amanda Kirkham, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2017
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trialPhilip Noel Newsome, Richard Fox, Andrew L King, et al.
Hepatology Communications|April 26, 2024
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trialGideon M Hirschfield, Katherine Arndtz, Amanda Kirkham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancerDaniel H Palmer, Vivien Mautner, Darius Mirza, et al.
Pageof 2